Cargando…
Metaplastic breast cancer: Treatment and prognosis by molecular subtype
BACKGROUND: Metaplastic breast cancer (MBC) is a rare and aggressive subtype of breast. However, the effect of molecular subtype on treatment and prognosis of MBC remains unclear. PATIENTS AND METHODS: The Surveillance, Epidemiology, and End Results database was used to analyze patients with MBC bet...
Autores principales: | Hu, Jin, Zhang, Huiqiong, Dong, Fang, Zhang, Ximeng, Wang, Shuntao, Ming, Jie, Huang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079171/ https://www.ncbi.nlm.nih.gov/pubmed/33677236 http://dx.doi.org/10.1016/j.tranon.2021.101054 |
Ejemplares similares
-
Single Hormone Receptor-Positive Metaplastic Breast Cancer: Similar Outcome as Triple-Negative Subtype
por: Mao, Jinqian, et al.
Publicado: (2021) -
The Effect of Post-Mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: A Propensity Score-Matched Analysis of the SEER Database
por: Hu, Jin, et al.
Publicado: (2022) -
Combination of serum lactate dehydrogenase and sex is predictive of severe disease in patients with COVID-19
por: Hu, Jin, et al.
Publicado: (2020) -
Presentation and survival by hormonal receptor status in metaplastic breast cancer: A propensity score-matched analysis
por: Wang, Siqin, et al.
Publicado: (2021) -
Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes
por: Moreno, Amy C., et al.
Publicado: (2020)